L&G PHARMA BREAKTHROUGH ETF |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.15 USD | +0.76% |
|
+0.88% | -13.95% |
| 2018 | ETFS Pharma Breakthrough GO UCITS ETF has Changed its Name to L&G Pharma Breakthrough UCITS ETF | CI |
Investment objective
The L&G Pharma Breakthrough UCITS ETF (the 'ETF') aims to track the performance of the Solactive Pharma Breakthrough Value Index (the 'Index').
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 282.4 SEK | +1.66% | +0.79% | +5.77% | 4.51% | ||
| 4,781 JPY | +1.90% | +0.70% | -10.50% | 4.07% | ||
| 37.57 USD | +2.79% | +0.78% | -25.74% | 4.01% | ||
| 37.4 EUR | +0.43% | +3.83% | -8.96% | 3.95% | ||
| 35.2 HKD | -0.14% | -1.95% | -17.66% | 3.82% | ||
| 455.3 USD | +2.77% | -0.35% | +11.91% | 3.73% | ||
| 2.84 HKD | +1.43% | -1.05% | -18.16% | 3.67% | ||
| 17.78 USD | -2.25% | -0.78% | -34.94% | 3.36% | ||
| 75.07 USD | +0.79% | -0.60% | -22.14% | 3.36% | ||
| 4.32 HKD | +0.47% | -5.47% | -37.30% | 3.34% | ||
More news
In partnership with
Description
| IE00BF0H7608 | |
|---|---|
| Total Expense Ratio | 0.49% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | Solactive Pharma Breakthrough Value NTR Index - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
21/01/2018
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 29/04/2024 )
| AuM (EUR) | 17 M€ |
|---|---|
| AuM 1M | 19 M€ |
| AuM 3 months | 24 M€ |
| AuM 6 months | 27 M€ |
| AuM 12 months | 59 M€ |
- Stock Market
- ETF
- BIOT ETF
